Great Novel Therapeutics Biotech & Medicals 7427.TWO Stock
Great Novel Therapeutics Biotech & Medicals Price Chart
Great Novel Therapeutics Biotech & Medicals 7427.TWO Financial and Trading Overview
Contents
- Great Novel Therapeutics Biotech & Medicals Price Chart
- Great Novel Therapeutics Biotech & Medicals 7427.TWO Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Great Novel Therapeutics Biotech & Medicals
- Q&A For Great Novel Therapeutics Biotech & Medicals Stock
| Great Novel Therapeutics Biotech & Medicals stock price | 56.5 TWD |
| Previous Close | 99.8 TWD |
| Open | 99.8 TWD |
| Bid | 99.8 TWD x N/A |
| Ask | 100.5 TWD x N/A |
| Day's Range | 98.6 - 101 TWD |
| 52 Week Range | 30.85 - 110 TWD |
| Volume | 328.24K TWD |
| Avg. Volume | 477.65K TWD |
| Market Cap | 3.23B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.7 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
7427.TWO Valuation Measures
| Enterprise Value | 2.66B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5974.711 |
| Price/Book (mrq) | 8.198717 |
| Enterprise Value/Revenue | 4932.498 |
| Enterprise Value/EBITDA | -47.839 |
Trading Information
Great Novel Therapeutics Biotech & Medicals Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 199.54% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 110 TWD |
| 52 Week Low | 30.85 TWD |
| 50-Day Moving Average | 90.78 TWD |
| 200-Day Moving Average | 62.42 TWD |
7427.TWO Share Statistics
| Avg. Volume (3 month) | 477.65K TWD |
| Avg. Daily Volume (10-Days) | 286.49K TWD |
| Shares Outstanding | 31.94M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -10636.66% |
| Gross Margin | 85.92% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -11.91% |
| Return on Equity (ttm) | -19.60% |
Income Statement
| Revenue (ttm) | 540K TWD |
| Revenue Per Share (ttm) | 0.02 TWD |
| Quarterly Revenue Growth (yoy) | -100.00000000000000000000000000000000% |
| Gross Profit (ttm) | 464K TWD |
| EBITDA | -55677000 TWD |
| Net Income Avi to Common (ttm) | -55779000 TWD |
| Diluted EPS (ttm) | -2.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 247.58M TWD |
| Total Cash Per Share (mrq) | 8.45 TWD |
| Total Debt (mrq) | 0 TWD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 20.873 |
| Book Value Per Share (mrq) | 12.319 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -68263000 TWD |
| Levered Free Cash Flow (ttm) | -54870752 TWD |
Profile of Great Novel Therapeutics Biotech & Medicals
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | 115, Building F |
| ZIP | N/A |
| Phone | 886 2 7722 0388 |
| Website | https://www.gntbm.com.tw/tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 14 |
Great Novel Therapeutics Biotech & Medicals develops drugs to treat advanced and refractory cancers. It develops drugs for epigenetic modulators, epiimmune modulators, tumor microenvironment modulators, and HDACs 1, 2, 3 protein degrading agents. The company was formerly known as GNT Biotech & Medicals Corporation. Great Novel Therapeutics Biotech & Medicals was founded in 2013 and is based in Taipei City, Taiwan.
Q&A For Great Novel Therapeutics Biotech & Medicals Stock
What is a current 7427.TWO stock price?
Great Novel Therapeutics Biotech & Medicals 7427.TWO stock price today per share is 56.5 TWD.
How to purchase Great Novel Therapeutics Biotech & Medicals stock?
You can buy 7427.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Great Novel Therapeutics Biotech & Medicals?
The stock symbol or ticker of Great Novel Therapeutics Biotech & Medicals is 7427.TWO.
Which industry does the Great Novel Therapeutics Biotech & Medicals company belong to?
The Great Novel Therapeutics Biotech & Medicals industry is Biotechnology.
How many shares does Great Novel Therapeutics Biotech & Medicals have in circulation?
The max supply of Great Novel Therapeutics Biotech & Medicals shares is 38.36M.
What is Great Novel Therapeutics Biotech & Medicals Price to Earnings Ratio (PE Ratio)?
Great Novel Therapeutics Biotech & Medicals PE Ratio is now.
What was Great Novel Therapeutics Biotech & Medicals earnings per share over the trailing 12 months (TTM)?
Great Novel Therapeutics Biotech & Medicals EPS is -1.7 TWD over the trailing 12 months.
Which sector does the Great Novel Therapeutics Biotech & Medicals company belong to?
The Great Novel Therapeutics Biotech & Medicals sector is Healthcare.